Literature DB >> 28126426

Lactulose Is Associated With Decreased Risk of Clostridium difficile Infection in Decompensated Cirrhosis.

Anant Agarwalla1, Andrew Weber2, Sonya Davey3, Keith Hamilton4, David Goldberg5, Andrew D Rhim6, Yu-Xiao Yang7.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28126426     DOI: 10.1016/j.cgh.2017.01.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  6 in total

1.  Outcomes among inpatients with cirrhosis and Clostridioides difficile infection in the modern era: results from an analysis of the National Inpatient Sample.

Authors:  Sentia Iriana; Sachit Sharma; Stephanie McDonough; Eduardo Rodriguez Zarate; Douglas G Adler
Journal:  Ann Gastroenterol       Date:  2021-06-14

Review 2.  Clostridioides difficile Infection in Liver Cirrhosis: A Concise Review.

Authors:  Yuanbin Liu; Mingkai Chen
Journal:  Can J Gastroenterol Hepatol       Date:  2022-06-07

3.  Systematic Review of the Economic Burden of Overt Hepatic Encephalopathy and Pharmacoeconomic Impact of Rifaximin.

Authors:  Guy Neff; Woodie Zachry
Journal:  Pharmacoeconomics       Date:  2018-07       Impact factor: 4.981

4.  Lactulose may reduce Clostridium difficile-related diarrhea among patients receiving antibiotics.

Authors:  Charles Maltz; Paul F Miskovitz; Kaveh Hajifathalian
Journal:  JGH Open       Date:  2020-07-09

5.  Multi-omics investigation of Clostridioides difficile-colonized patients reveals pathogen and commensal correlates of C. difficile pathogenesis.

Authors:  Skye Rs Fishbein; John I Robinson; Tiffany Hink; Kimberly A Reske; Erin P Newcomer; Carey-Ann D Burnham; Jeffrey P Henderson; Erik R Dubberke; Gautam Dantas
Journal:  Elife       Date:  2022-01-27       Impact factor: 8.140

6.  Incidence and Risk Factors of Recurrent Clostridioides difficile Infection in Patients With Cirrhosis.

Authors:  Parkpoom Phatharacharukul; Russell D Purpura; Devika Gandhi; Huiping Xu; Katie Bickett-Burkhart; Naga Chalasani; Monika Fischer; Eric S Orman
Journal:  Clin Transl Gastroenterol       Date:  2020-07       Impact factor: 4.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.